Clinical trial shows new treatment for a rare and aggressive cancer improves survival rates

The phase 3 clinical trial, published recently in JAMA Oncology and sponsored by Polaris Pharmaceuticals, has unveiled a breakthrough in the treatment of malignant pleural mesothelioma (MPM), a rare and often rapidly fatal form of cancer associated with asbestos exposure and which has limited therapeutic options. The trial found that a combination treatment of traditional […]

About Hashtag: HealthNews